Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,708,120
+$11,228,792 QoQ
Shares Held
1,542,000
+60.2% QoQ
Ownership
1.73%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#21
of 242 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. SNDX ranks #29 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in SNDX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,708,120 | 1,542,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $22,479,328 | 962,300 | Shares | Defined | 2026-05-15 | |
| 2024-09-30 | $37,062,025 | 1,925,300 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $39,526,409 | 1,925,300 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $41,626,200 | 1,749,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $37,795,890 | 1,749,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,643,680 | 1,284,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $52,957,923 | 2,530,240 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,150,576 | 1,711,675 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $51,065,425 | 2,006,500 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $48,216,195 | 2,006,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $44,700,292 | 2,323,300 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $37,511,254 | 2,158,300 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $43,370,657 | 1,981,300 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,642,366 | 190,600 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $26,040,816 | 1,170,900 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $16,148,916 | 1,094,100 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $16,214,562 | 1,094,100 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,181,300 | 290,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||